INTERNATIONAL PATENT: VECTIVBIO AG FILES APPLICATION FOR "GLUCAGON-LIKE PEPTIDE 2 (GLP-2) ANALOGS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE"

GENEVA, Oct. 6 -- VECTIVBIO AG (Aeschenvorstadt 364051 Basel) filed a patent application (PCT/US2025/022048) for "GLUCAGON-LIKE PEPTIDE 2 (GLP-2) ANALOGS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE" on Mar 28, 2025. With publication no. WO/2025/208047, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADELMANN, Holger (c/o VectivBio AGAeschenvorstadt 364051 Basel), YOUSSEF, Nader Namir (2250 Lamington Rd.Bedminster, New Jersey 07921), LOBRUTTO, Rosario (2 Dawn LaneRandolph, New Jersey 07869), MATHEZ, Julien (Route d'Yver...